{"id":"F2008B00064","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 17 of 1993)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72238,"registerId":"commonwealth-F2008B00064-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 17 of 1993)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 17 of 1993\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health, Housing, Local Government and Community Services and Delegate of the Minister for Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 December 1993.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAmoxycillin Sodium\n\n“Maxamum XP”\n\nRolitetracycline\n\nTrioxysalen\n\nDated this fifteenth day of November 1993.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health, Housing, Local Government and Community Services\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2216},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration operates strictly within the original scope of subsection 85(2AA) of the National Health Act 1953, which expressly authorises the removal of drugs from the Pharmaceutical Benefits Scheme. The instrument delists four specific pharmaceutical items, consistent with the enabling provision's intended purpose of updating the PBS formulary based on medical or cost-effectiveness assessments."},"complexity_factors":["Very short instrument consisting of a single operative clause and a four-item schedule","No conditional logic or exceptions — the legal effect is absolute and immediate","Minimal cross-referencing (only cites the empowering provision section 85(2AA))","Straightforward administrative action requiring no interpretive gymnastics"],"plain_english_summary":"From 1 December 1993, four named medicines — Amoxycillin Sodium, Maxamum XP, Rolitetracycline and Trioxysalen — were removed from Australia’s Pharmaceutical Benefits Scheme, meaning they are no longer government‑subsidised and must be paid for privately if prescribed. The decision was made by a Health Department delegate following advice from the Pharmaceutical Benefits Advisory Committee."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-17-of-1993/documents"}}